Stay updated on Bemcentinib in AML/MDS Clinical Trial
Sign up to get notified when there's something new on the Bemcentinib in AML/MDS Clinical Trial page.

Latest updates to the Bemcentinib in AML/MDS Clinical Trial page
- CheckyesterdayNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe page’s release/build revision indicator has been updated from `v3.5.2` to `v3.5.3` at the bottom of the ClinicalTrials.gov page.SummaryDifference0.0%

- Check23 days agoChange DetectedRevision: v3.5.2 has been added and Revision: v3.5.0 has been removed.SummaryDifference0.0%

- Check52 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check66 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3. No visible changes to study details or page layout.SummaryDifference0.0%

- Check87 days agoChange DetectedRevision updated from v3.4.1 to v3.4.2; no substantive changes to the study details, eligibility criteria, locations, or outcome measures were observed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check94 days agoChange DetectedThe page now shows an updated revision tag (v3.4.1) replacing the previous v3.4.0; this is a minor metadata update and does not affect study details, locations, or eligibility information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Bemcentinib in AML/MDS Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Bemcentinib in AML/MDS Clinical Trial page.